TP53 and Burkitt lymphoma: In fact, in a previously reported screen involving HSPCs and pQCiG to identify oncogenic drivers in Burkitt’s lymphoma, we were restricted to using pools of only 5 sgRNAs since pools of 20 sgRNAs failed to identify p53 as an oncogenic driver (Katigbaket al. 2016).